[Effect of desferal therapy on indices of iron metabolism in patients with intermediate forms of beta-thalassemia].
Efendieva
E G
EG
Dashkova
N G
NG
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D005914:Globins / Q000235:genetics; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008297:Male; D013789:Thalassemia / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
D007502:Iron Chelating Agents; D005914:Globins; D007501:Iron; D003676:Deferoxamine
Vliianie desferaloterapii na pokazateli obmena zheleza u bol'nykh s promezhutochnoĭ formoĭ beta-talassemii.